New Advances in Chemical Research, May 2021. Reference of 2682-49-7, Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction by binding to a specific portion of an enzyme and thus slowing or preventing a reaction from occurring. In a document type is Patent, and a compound is mentioned, 2682-49-7, Thiazolidin-2-one, introducing its new discovery.
Chloro-4 – [3 – 4-() cyclopropylamino) carbonylamino-] – 7 – carbonylmethoxy-6-(I) quinolinecarboxazolone and application thereof, and the structure accords with the formula of the compound of the general formula shown in the specification. The drug has weak drug effect under normal conditions, is unstable in a high free radical environment, and can generate molecules with stronger drug effect. The medicine has good drug effect and safety, and can be used for treating tumor drugs. (by machine translation)
We’ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 2682-49-7, and how the biochemistry of the body works.Reference of 2682-49-7
Reference：
Quinuclidine – Wikipedia,
Quinuclidine | C7H191N | ChemSpider